-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Taysha Gene Therapies, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
- Taysha Gene Therapies, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$25.5M, a 78.2% increase year-over-year.
- Taysha Gene Therapies, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$22.8M, a 89.4% increase year-over-year.
- Taysha Gene Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$112M, a 32.8% increase from 2022.
- Taysha Gene Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$166M, a 4.88% increase from 2021.
- Taysha Gene Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$175M, a 191% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)